Genkyotex’s setanaxib shows favourable safety profile in Phase I trial
French biopharmaceutical firm Genkyotex has reported positive data from the Phase I trial of its lead product candidate, setanaxib (GKT831),…
French biopharmaceutical firm Genkyotex has reported positive data from the Phase I trial of its lead product candidate, setanaxib (GKT831),…
Swiss biopharmaceutical firm Debiopharm has started the dosing of the first patient in a Phase II proof-of-concept clinical trial of its antiviral alisporivir (Debio 025) for treating hospitalised Covid-19 patients.…
Grifols is set to initiate a clinical trial in Spain to analyse a new Covid-19 drug, which can potentially offer immediate post-exposure protection against the SARS-CoV-2 virus. An anti-SARS-CoV-2 immunoglobulin,…
Clinical-stage biopharma firm Seelos Therapeutics has dosed the first patients in its registrational 'Proof of Concept' study to evaluate SLS-002 (intranasal racemic ketamine) for acute suicidal ideation and behaviour in…
Dr Reddy’s Laboratories is all set to conduct a Phase III clinical trial of the Covid-19 vaccine, Sputnik V, after it received approval from the Drugs Control General of India…
Cyxone has announced the screening of the first participant in the Phase II clinical trial to evaluate Rabeximod for treating Covid-19 patients. The trial is analysing the efficacy and safety…
Mirum Pharmaceuticals has enrolled the first patient in its Phase IIb VISTAS study of volixibat in adult patients with primary sclerosing cholangitis (PSC), an idiopathic chronic cholestatic liver disease. An…